Prostate Cancer Clinical Trial

Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study

Summary

The purpose of this study is to quantify and publish participants' relative preferences for outcomes of chemotherapy and novel oral hormonal agents when added to androgen deprivation therapy (ADT) for participants with locally-advanced and metastatic hormone-sensitive prostate cancer (mHSPC). This study will also quantify the importance of administration factors related to convenience relative to treatment outcomes.

View Full Description

Full Description

The study will develop and administer a discrete-choice experiment (DCE) to quantify tradeoff preferences of participants with mHSPC and locally-advanced prostate cancer in various countries. Data/surveys are being collected in: United States, Canada, UK, France, Spain, Japan, China and South Korea.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

For interviews (attribute prioritization and pretest interviews)

Diagnosis of mHSPC with or without previous experience with ADT
Able to read and understand the survey language
Able to provide informed consent For online survey
Diagnosis of mHSPC or locally-advanced prostate cancer with or without previous experience with ADT
Able to read and understand the survey language
Able to provide informed consent

Exclusion Criteria:

Not applicable

Study is for people with:

Prostate Cancer

Estimated Enrollment:

1200

Study ID:

NCT05381311

Recruitment Status:

Recruiting

Sponsor:

Astellas Pharma Global Development, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Duke Clinical Research Institute
Durham North Carolina, 27701, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

1200

Study ID:

NCT05381311

Recruitment Status:

Recruiting

Sponsor:


Astellas Pharma Global Development, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.